Search the Newsroom
Filter By
Showing 1 - 10 of 2851 results
American Society of Gene and Cell Therapy Awards Beverly L. Davidson, PhD, Outstanding Achievement Award
CHOP is pleased to announce that Beverly L. Davidson, PhD, Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Chief Scientific Strategy Officer at CHOP, and Professor of Pathology and Laboratory Medicine at Penn Medicine, received the American Society of Gene and Cell Therapy (ASGCT) Outstanding Achievement Award, the society’s highest honor.
The National Academy of Medicine Names Lindsey A. George, MD, to its 2026 class of Emerging Leaders in Health and Medicine
Children’s Hospital of Philadelphia (CHOP) announced today that the National Academy of Medicine (NAM) named Lindsey A. George, M.D., Director of Clinical In Vivo Gene Therapy, and an attending physician in the Division of Hematology at CHOP, as a member of its 2026 class of Emerging Leaders in Health and Medicine (ELHM) scholars.
Analysis of Brain Tumor Following AAV Gene Therapy Identifies Vector Integration and Reinforces Importance of Long-Term Monitoring
CHOP researchers reported today in the New England Journal of Medicine about a rare but noteworthy outcome in a child treated with an adeno-associated virus (AAV) gene therapy for severe mucopolysaccharidosis type I (MPS I). MPS I, a lysosomal storage disorder also known as Hurler Syndrome, is characterized by an abnormal build-up of various toxic materials, called glycosaminoglycans (GAGs) in the body's cells.
Highlights from the Pediatric Orthopaedic Society of America (POSNA) 2026 Annual Meeting
Children’s Hospital of Philadelphia (CHOP) physicians presented new and updated research data, including 25 ePosters and 22 presentations, at the Pediatric Orthopaedic Society of America (POSNA) annual conference in Orlando, Florida, May 6–8, 2026.
High Dose Proton Re-Irradiation Shows Promise for Children with Recurrent Brain and Spinal Cord Tumors
Researchers at CHOP report a retrospective study showing high dose proton re irradiation can be feasible and well tolerated for select children and young adults with recurrent CNS tumors.
Gene Editing Innovators Receive 2026 Catalyst Award at American Society of Gene & Cell Therapy’s Annual Conference
Children’s Hospital of Philadelphia (CHOP), Danaher Corporation, the Innovative Genomics Institute (IGI), and Penn Medicine celebrate members of their teams as the 2026 recipients of the American Society of Gene & Cell Therapy’s (ASGCT) Catalyst Award.
Children’s Hospital of Philadelphia Selects Jesse A. Taylor, MD, as Surgeon-in-Chief
Children’s Hospital of Philadelphia (CHOP) is pleased to announce that Jesse A. Taylor, MD, Chief of the Division of Plastic, Reconstructive and Oral Surgery at CHOP, has been selected as the new Surgeon-in-Chief and Chair of the Department of Surgery, effective July 1, 2026, following a competitive national search.
Feature Article — Consequences of Unfounded Vaccine Safety Concerns: Where Do the Real Risks Lie? (Part 1)
Part 1 of this three-part series examines concerns about the safety of donated blood. These concerns result from unfounded fears about COVID-19 vaccine safety.
Vaccine News & Notes — May 2026
Do you know the difference between insect repellents and insecticides? Find out about this and other news, including infectious disease numbers so far in 2026.
"Just the Vax" Trivia Corner
In what city did people first organize to voice their concerns about vaccinations? Find out.